Articles From: Microchip Technology Raises Guidance For Third Quarter Of Fiscal 2015 to Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy


CHANDLER, Ariz.
Sign-up for Microchip Technology Raises Guidance For Third Quarter Of Fiscal 2015 investment picks
Physicians Realty Trust (NYSE:DOC) (the “Company”), a self-managed healthcare real estate company, announced today that it has adopted a Dividend Reinvestment and Share Purchase Plan (the "Plan"). Under the Plan: Governor Tommy G.
Sign-up for Physicians Realty Trust Announces Dividend Reinvestment and Share Purchase Plan investment picks
SAN JOSE, Calif.
Sign-up for Synaptics to Present at BMO Technology & Digital Media Conference investment picks
Humana Inc. (NYSE: HUM) announced that it will be hosting an Investor Meeting in New York City on Thursday, December 4, 2014, at 9:00 a.m. eastern time.
Sign-up for Humana to Host Biennial Investor Meeting investment picks
Cooper Tire & Rubber Company (NYSE: CTB) today announced that its board of directors has elected Ginger M.
Sign-up for Cooper Tire Names New Chief Financial Officer investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982216001&sourceType=1 http://www.ccnmatthews.com/logos/20051130-pin200.jpg TORONTO, CANADA --
Sign-up for Pinetree Capital Announces Status of Convertible Debenture Debt Incurrence Covenant investment picks
VERNON HILLS, Ill., Dec.
Sign-up for CDW Corporation Announces Commencement of Public Offering by Selling Stockholders investment picks
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, today provided an update on the timeline for filing its New Drug Application (NDA) for the approval of PB272 (neratinib) in the extended adjuvant treatment of HER2-positive early stage breast cancer.
Sign-up for Puma Biotechnology Updates Timeline for Filing New Drug Application investment picks
NEW YORK, Dec.
Sign-up for StoneCastle Financial Announces Dividend for Fourth Quarter 2014 investment picks
The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared an additional year-end cash distribution of $0.14 per share payable on December 19, 2014 to common shareholders of record on December 12, 2014.
Sign-up for Gabelli Healthcare & WellnessRx Trust Declares Additional Distribution of $0.14 Per Share investment picks
Fifth Third Bancorp (Nasdaq: FITB) is scheduled to report fourth quarter 2014 financial results on January 21, 2015.
Sign-up for Fifth Third Bancorp to Announce Fourth Quarter 2014 Results, Host Conference Call on January 21, 2015 at 9:00 AM investment picks
2015 Dividends to Increase 14 Percent TULSA, Okla.
Sign-up for ONEOK Announces Higher 2015 Financial Guidance; Updates Three-year Financial Forecasts investment picks
A.M. Best has affirmed the financial strength rating of A- (Excellent) and the issuer credit ratings (ICR) of “a-” of Madison National Life Insurance Company, Inc. (Madison National) (Madison, WI), Standard Security Life Insurance Company of New York (Standard Security) (New York, NY) and Independence American Insurance Company (Independence American) (New Castle, DE), all subsidiaries of Independence Holding Company (Independence Holding) (headquartered in Stamford, CT) [NYSE:IHC]. Concurrently, A.M. Best has affirmed the ICR of “bbb-” of Independence Holding.
Sign-up for A.M. Best Affirms Ratings of Independence Holding Company and Its Subsidiaries investment picks
Aerohive Networks® (NYSE:HIVE), a leader in controller-less Wi-Fi and cloud-managed mobile networking for the enterprise market, today announced that management will present at the Barclays Global Technology Conference on Tuesday, December 9, at 3:00 p.m. PT.
Sign-up for Aerohive to Present at the Barclays Global Technology Conference on December 9 investment picks
Staples, Inc. (Nasdaq: SPLS) announced today that its Board of Directors has declared a quarterly cash dividend on Staples, Inc. common stock of $0.12 per share.
Sign-up for Staples, Inc. Announces Fourth Quarter 2014 Dividend investment picks
Fifth Third Bancorp (Nasdaq: FITB) will present at the Goldman Sachs U.S. Financial Services Conference in New York City on Tuesday, December 9 at approximately 2:40 PM ET.
Sign-up for Fifth Third Bancorp to Present at the 2014 Goldman Sachs U.S. Financial Services Conference investment picks
2015 Adjusted EBITDA Expected to Increase 19 Percent 2015 Unitholder Distributions to Increase 8 Percent TULSA, Okla.
Sign-up for ONEOK Partners Announces Higher 2015 Financial Guidance; Updates Three-year Financial Forecasts investment picks
http://media.marketwire.com/attachments/201407/264276_vert_2C_logo_tag.eps.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162593&ProfileId=051205&sourceType=1 REDWOOD CITY, CA --
Sign-up for Qualys to Present at Upcoming Investor Conferences investment picks
Redwood City, CA, Dec.
Sign-up for Informatica to Present At Credit Suisse Annual Technology Conference investment picks
http://media.marketwire.com/attachments/201101/18984_VerisignNew.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162596&ProfileId=051205&sourceType=1 RESTON, VA --
Sign-up for Internet Grows to 280 Million Domain Names in the Second Quarter of 2014 investment picks
Guidewire Software, Inc. (NYSE: GWRE), a provider of software products for property and casualty insurers, today announced its financial results for the fiscal quarter ended October 31, 2014.
Sign-up for Guidewire Software Announces First Quarter Fiscal 2015 Financial Results investment picks
Conference Call Scheduled for Wednesday, December 3rd to Provide Investor Update SAN DIEGO , Dec.
Sign-up for Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration investment picks
STATESVILLE, N.C. , Dec.
Sign-up for Kewaunee Scientific Reports Results for Second Quarter investment picks
STAMFORD, Conn.
Sign-up for Information Services Group Declares a Special Dividend Of $0.14 Per Share investment picks
Posters Include an Epidemiological Measure of the Effectiveness Analysis of Defibrotide from a Phase 3 Trial in Severe Hepatic VOD, as well as Updates from an International Compassionate Use Program and a U.S. Treatment IND Study DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting investment picks
Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Microchip Technology Raises Guidance For Third Quarter Of Fiscal 2015 to Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent